{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Pharmacy%20Plus%2C%20Inc.%2C%20dba%20Vital%20Care%20Compounder","name":"Pharmacy Plus, Inc., dba Vital Care Compounder","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-07T08:48:54.074Z"},"count":1,"matches":[{"id":"12b160434d6c1c58","posted_date":"2023-06-13","letter_issue_date":"2023-06-06","company_name":"Pharmacy Plus, Inc., dba Vital Care Compounder","issuing_office":"Division of Pharmaceutical Quality Operations II","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.morvs.ai/fda-warning/12b160434d6c1c58"}]}